Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2006 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY.
Retina. 2019 Apr;39(4):761-765. doi: 10.1097/IAE.0000000000002007.
Retina. 2019.
PMID: 29293206
PURPOSE: To describe a crystalline retinopathy observed in patients greater than 1 year after intravitreal injection of triamcinolone acetonide (IVTA). ...Optical coherence tomography confirmed the preretinal and/or subhyaloid location of crystals. CONCLUSION: Macular …
PURPOSE: To describe a crystalline retinopathy observed in patients greater than 1 year after intravitreal injection of triamcinolone …
Intraocular crystals in HIV-related hypergammaglobulinemia.
Traill A, Zamir E, Russell D.
Traill A, et al.
Ocul Immunol Inflamm. 2006 Feb;14(1):63-5. doi: 10.1080/09273940500545619.
Ocul Immunol Inflamm. 2006.
PMID: 16507495
PURPOSE: To describe the occurrence of bilateral iris and retinal crystals in a patient with benign HIV-related gammopathy. DESIGN: Observational case report. METHODS: A 45-year-old HIV-positive male with a known, benign hypergammaglobulinemia was referred for routine opht …
PURPOSE: To describe the occurrence of bilateral iris and retinal crystals in a patient with benign HIV-related gammopathy. DESIGN: Obser …
Item in Clipboard
Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.
Parkkari M, Paakkala AM, Salminen L, Holli K; Finnish Breast Cancer Group.
Parkkari M, et al.
Acta Ophthalmol Scand. 2003 Oct;81(5):495-9. doi: 10.1034/j.1600-0420.2003.00116.x.
Acta Ophthalmol Scand. 2003.
PMID: 14510798
Free article.
Clinical Trial.
Ten patients developed cataract during the study period (five in each group), giving annual cataract rates of 6.8% and 6.2% in the tamoxifen and toremifene groups, respectively. Three patients had macular crystals at the first visit (one in the tamoxifen group and t …
Ten patients developed cataract during the study period (five in each group), giving annual cataract rates of 6.8% and 6.2% in the tamoxifen …
Item in Clipboard
Cite
Cite